盐酸氨溴索治疗慢性阻塞性肺病合并肺感染的临床价值分析

Analysis of the clinical value of ambroxol hydrochloride in the treatment of chronic obstructive pulmonary disease complicated with lung infection

目的:分析盐酸氨溴索治疗慢性阻塞性肺病(简称慢阻肺)合并肺感染的临床价值。方法:2018年1月-2020年12月收治慢阻肺合并肺感染患者108例,随机分为两组,各54例。对照组采用常规治疗;观察组在常规治疗基础上采用盐酸氨溴索治疗。比较两组治疗效果。结果:观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05);观察组各项临床症状改善时间均短于对照组,差异有统计学意义(P<0.05);观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论:采用盐酸氨溴索治疗慢阻肺合并肺感染,有利于提高治疗效果,改善临床症状,降低不良反应。

Objective:To analyze the clinical value of ambroxol hydrochloride in the treatment of COPD complicated with lung infection.Methods:From January 2018 to December 2020,108 cases of patients with COPD complicated with pulmonary infection were enrolled,they were randomly divided into two groups with 54 cases in each group.The control group used routine treatment.The observation group used ambroxol hydrochloride on the basis of routine treatment.The therapeutic effects between the two groups was compared.Results:The total effective rate of treatment in observation group was higher than that in control group,the difference was statistically significant(P<0.05).The improvement time of each clinical symptom in the observation group was shorter than that in the control group,the differences were statistically significant(P<0.05).The improvement time of all clinical symptoms in the observation group was shorter than that in the control group,the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Ambroxol hydrochloride in the treatment of chronic obstructive pulmonary disease with lung infection is beneficial to improve the therapeutic effect,improve clinical symptoms and reduce adverse reactions.